The theme of the week is consequences. When micro-cap companies stretch the rules or run out of cash, the rubber eventually meets the road. This week, we saw a total equity wipeout disguised as a Canadian buyout, an apparel roll-up cancelling its own warrants to fight off silent partners, and a luxury skiwear brand experiencing a boardroom avalanche.
Digital Brands Group (DBGI): The Warrant Vigilantes
Usually, when micro-caps get caught in toxic financing spirals, they just dilute until the lights go out. Digital Brands Group took a different route: they unilaterally cancelled 7.1 million pre-funded warrants. The apparel roll-up claims it uncovered a concerted effort by warrant holders to breach 4.99% beneficial ownership caps using "foreign silent partners" and transfer agent manipulation. To add to the chaos, they just let another 9.6 million cash warrants expire to clear out the dilution overhang. DBGI shares have lost 91% of their value over the last year, leaving a market cap of roughly $4 million. Canceling warrants pending a legal investigation is a fascinating defense mechanism, but when your current ratio is 0.72, you are fighting a multi-front war.
Sleep Number (SNBR): Taylor Swift's Boyfriend Gets Wiped Out
Sleep Number has officially filed for Chapter 11 and received its delisting notice from Nasdaq. The maker of adjustable smart beds entered bankruptcy with $672 million in debt, blaming the usual suspects: tariffs and inflation. The endgame is a $415 million stalking-horse bid from Sleep Country Canada. Sleep Number secured $260 million in debtor-in-possession financing to keep its 572 retail stores operating while the auction plays out. The best part of this filing? The company recently signed an endorsement deal with NFL star Travis Kelce, giving him a 5% equity stake. That equity is now almost certainly worth zero.
Perfect Moment (PMNT): Boardroom Avalanche
Luxury skiwear brand Perfect Moment is moving its listing from the NYSE American to the OTCQB, and its leadership team decided not to make the trip. The company announced the resignation of its CFO/COO Chath Weerasinghe alongside three non-executive directors. SEC filings indicate two directors quit over disagreements regarding "strategic direction" and the third over "corporate governance," entirely gutting the audit and compensation committees. Downgrading to the OTC while your principal accounting officer walks out the door is the classic sequence for losing institutional capital.
Assertio Holdings (ASRT): The $166 Million Bailout
Assertio is officially off the public markets after Zydus Worldwide closed its acquisition for $23.50 per share in cash. This is a rare micro-cap win. Zydus swooped in to top an existing agreement with Garda Therapeutics, paying a 76% premium to Assertio's unaffected March price. The merger triggered fundamental change and make-whole provisions on $40 million of convertible debt due in 2027, creating an immediate repurchase obligation. Zydus is happily eating the debt to get Assertio's specialty oncology infrastructure in the U.S..
Dyadic International (DYAI): Out of Extensions
Nasdaq has initiated delisting proceedings against biotech firm Dyadic International. Missing the $1.00 minimum bid price is standard behavior on the lower exchanges, but Dyadic failed to maintain the $5 million in shareholders' equity required to get an automatic 180-day extension. The company is requesting a hearing before an independent panel to stay the suspension, hoping to buy time until December. With shares hovering around $0.80, deep operating losses, and a deteriorated balance sheet, the hearing panel is just a delay tactic for a company openly warning about its ability to continue as a going concern.
What to Watch
Keep an eye on DBGI's legal fallout. Unilaterally canceling pre-funded warrants is a nuclear option that will almost certainly trigger immediate litigation from the warrant holders. Meanwhile, Sleep Number's bankruptcy auction is set for July 13. Watch to see if any competing bids emerge, or if Sleep Country Canada takes the whole bed.